Kristen received her BS in Molecular Biology from Brigham Young University. After graduation she began working in laboratory operations in the areas of hereditary cancer genetics and, later, forensic science. Kristen continued her education at the University of Utah where she received an MBA. She has worked in both the drug development and molecular diagnostic development for the past 12 years most recently with Myriad Genetics where she build and led the clinical operations department. In her free time Kristen loves to travel and spend time with her family.
Are you Recursion ready?
Join our passionate, innovative team—and help us realize our goal of 100 treatments by 2025.